Cargando…

Molecular determinants of context-dependent progesterone receptor action in breast cancer

The ovarian steroid hormone, progesterone, and its nuclear receptor, the progesterone receptor, are implicated in the progression of breast cancer. Clinical trial data on the effects of hormone replacement therapy underscore the importance of understanding how progestins influence breast cancer grow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagan, Christy R, Lange, Carol A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929904/ https://www.ncbi.nlm.nih.gov/pubmed/24552158 http://dx.doi.org/10.1186/1741-7015-12-32

Ejemplares similares

A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells
por: Hagan, Christy R., et al.
Publicado: (2013)

Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer
por: Walter, Katherine R., et al.
Publicado: (2020)

90 YEARS OF PROGESTERONE: Molecular mechanisms of progesterone receptor action on the breast cancer genome
por: Beato, Miguel, et al.
Publicado: (2020)

Context-dependent effects of cellular senescence in cancer development
por: Lecot, Pacome, et al.
Publicado: (2016)

Progesterone in gender-affirming therapy of trans women
por: Milionis, Charalampos, et al.
Publicado: (2022)

Genome-wide analysis of the context-dependence of regulatory networks
por: Papp, Balázs, et al.
Publicado: (2005)

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010)

Molecular profiling of breast cancer: clinical implications
por: Cleator, S, et al.
Publicado: (2004)

Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression
por: Panupinthu, N, et al.
Publicado: (2010)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers
por: Mehlen, P, et al.
Publicado: (2005)

Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy
por: Hanby, A M
Publicado: (2005)

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
por: Lianidou, E S, et al.
Publicado: (2013)

Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2018)

Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies
por: Kim, Jeong M., et al.
Publicado: (2013)

Saccharomyces cerevisiae metabolism in ecological context
por: Jouhten, Paula, et al.
Publicado: (2016)

Molecular Mechanism of Runx2-Dependent Bone Development
por: Komori, Toshihisa
Publicado: (2020)

Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor
por: Rao, Zhou-Zhou, et al.
Publicado: (2023)

Allosteric Molecular Switches in Metabotropic Glutamate Receptors
por: Orgován, Zoltán, et al.
Publicado: (2020)

Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
por: Abunada, Aya, et al.
Publicado: (2023)

Deciphering the mechanisms of action of progesterone in breast cancer
por: Chakravorty, Gaurav, et al.
Publicado: (2023)

The future of marginal kidney repair in the context of normothermic machine perfusion
por: DiRito, Jenna R., et al.
Publicado: (2018)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Understanding the Stringent Response: Experimental Context Matters
por: Dworkin, Jonathan
Publicado: (2023)

The role of microRNAs in glucocorticoid action
por: Clayton, Sally A., et al.
Publicado: (2018)

Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer
por: Rigas, B, et al.
Publicado: (2008)

Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy
por: Beloueche-Babari, M, et al.
Publicado: (2010)

Challenges in liver transplantation in the context of a major pandemic
por: Theocharidou, Eleni, et al.
Publicado: (2022)

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
por: Traish, A M, et al.
Publicado: (2009)

Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways
por: Manes, Nathan P., et al.
Publicado: (2021)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

Characterization of Structural Variations in the Context of 3D Chromatin Structure
por: Kim, Kyukwang, et al.
Publicado: (2019)

Targeting molecular addictions in cancer
por: Vivanco, I
Publicado: (2014)

Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer
por: Dwyer, Amy R., et al.
Publicado: (2020)

History of the dopamine hypothesis of antipsychotic action
por: Seeman, Mary V
Publicado: (2021)

Elucidating the Mechanisms of Action of Antimicrobial Agents
por: Hudson, M. Ashley, et al.
Publicado: (2022)

Reasons for breast cancer heterogeneity
por: Bertucci, François, et al.
Publicado: (2008)

Lipid droplets as metabolic determinants for stemness and chemoresistance in cancer
por: Royo-García, Alba, et al.
Publicado: (2021)

Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors
por: Kurdi, Maher, et al.
Publicado: (2023)

The Role of Progesterone Receptors in Breast Cancer
por: Li, Zhuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grv51eich0eb20p5u6q3tucs5j